PHAXIAM Financial Statements From 2010 to 2026
PHAXIAM Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing PHAXIAM Therapeutics' valuation are provided below:PHAXIAM Therapeutics SA does not today have any fundamental measures for analysis.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median.
Check PHAXIAM Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PHAXIAM Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . PHAXIAM financial statements analysis is a perfect complement when working with PHAXIAM Therapeutics Valuation or Volatility modules.
PHAXIAM |
PHAXIAM Therapeutics SA Company Return On Equity Analysis
PHAXIAM Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current PHAXIAM Therapeutics Return On Equity | -0.39 |
Most of PHAXIAM Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PHAXIAM Therapeutics SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, PHAXIAM Therapeutics SA has a Return On Equity of -0.3862. This is 98.39% lower than that of the Biotechnology sector and 98.94% lower than that of the Health Care industry. The return on equity for all United States stocks is 24.58% higher than that of the company.
PHAXIAM Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PHAXIAM Therapeutics's current stock value. Our valuation model uses many indicators to compare PHAXIAM Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PHAXIAM Therapeutics competition to find correlations between indicators driving PHAXIAM Therapeutics's intrinsic value. More Info.PHAXIAM Therapeutics SA is considered to be number one stock in return on equity category among its peers. It is regarded third in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value PHAXIAM Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in PHAXIAM Stock
If you are still planning to invest in PHAXIAM Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PHAXIAM Therapeutics' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |